World Health Organization (WHO)-supported study assessing the laboratory safety and immunogenicity profiles of a Sudan Ebola Virus vaccine among primary contacts of active Ebola cases in Uganda

Description

The study was conducted as an add-on component to the Solidarity Against Ebola (Tokomeza Ebola) initiative and focused on evaluating vaccine-induced immune responses, participant safety, and operational feasibility during outbreak response interventions